[PDF][PDF] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

PM Elliott, A Anastasakis, MA Borger… - Kardiologia Polska …, 2014 - journals.viamedica.pl
Kardiomiopatie definiuje się jako strukturalne oraz funkcjonalne nieprawidłowości mięśnia
komór, które nie wynikają z niedokrwienia na skutek choroby wieńcowej czy …

Update on hypertrophic cardiomyopathy and a guide to the guidelines

S Sen-Chowdhry, D Jacoby, JC Moon… - Nature Reviews …, 2016 - nature.com
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder,
affecting 1 in 500 individuals worldwide. Existing epidemiological studies might have …

Hypertrophic cardiomyopathy: a practical approach to guideline directed management

SR Ommen, C Semsarian - The Lancet, 2021 - thelancet.com
Hypertrophic cardiomyopathy, one of the most common genetic cardiovascular conditions,
will be encountered by nearly every health-care provider regardless of specialty. In 2020 …

Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review

BJ Maron, MY Desai, RA Nishimura, P Spirito… - Journal of the American …, 2022 - jacc.org
Hypertrophic cardiomyopathy (HCM) is a relatively common often inherited global heart
disease, with complex phenotypic and genetic expression and natural history, affecting both …

The diagnosis of hypertrophic cardiomyopathy

ED Wigle - Heart, 2001 - heart.bmj.com
Heart: first published as 10.1136/heart. 86.6. 709 on 1 December 2001. Downloaded from
heart disease at a relatively young age, HCM is a distinct possibility. That possibility is …

[HTML][HTML] Hypertrophic cardiomyopathy: genetics and clinical perspectives

CM Wolf - Cardiovascular diagnosis and therapy, 2019 - ncbi.nlm.nih.gov
Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and
defined by unexplained isolated progressive myocardial hypertrophy, systolic and diastolic …

American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines …

BJ Maron, WJ McKenna, GK Danielson… - European Heart …, 2003 - iris.unipv.it
Hypertrophic cardiomyopathy is a complex and relatively common genetic cardiac disorder
(about 1: 500 in the general adult population) 1that has been the subject of intense scrutiny …

Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis

Q Liu, D Li, AE Berger, RA Johns, L Gao - Scientific Reports, 2017 - nature.com
Hypertrophic cardiomyopathy (HCM) is a clinically and genetically heterogeneous disorder
but data on survival rates are still conflicting and have not so far been quantitatively …

Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death

WJ McKenna, ER Behr - Heart, 2002 - heart.bmj.com
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac muscle disorder disease that
affects sarcomeric proteins, resulting in small vessel disease, myocyte and myofibrillar …

[HTML][HTML] The diagnosis and treatment of hypertrophic cardiomyopathy

C Prinz, M Farr, D Hering, D Horstkotte… - Deutsches Ärzteblatt …, 2011 - ncbi.nlm.nih.gov
Methods In this article, we summarize the current state of the diagnosis and treatment of
HCM on the basis of a selective review of recent publications with relevance to clinical …